Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of medications called JAK inhibitors, using an acronym that assumes the ...

A new study reveals that modifying the CUL5 gene enhances CAR-T cell therapy for leukemia and lymphoma. This improves cell ...

JAKs are a family of intracellular non-receptor tyrosine kinases that transduce cytokine-mediated signals via the JAK–STAT pathway. More than 20 clinical trials are currently investigating JAK ...

Kuick Research Report Highlights Ongoing Developments In Molecular Switches Application Therapeutic Targets & Drug Delivery ...